Fairhope, ALNCT07181109Now EnrollingIRB Ready

High Risk Cardiovascular Disease Clinical Trial in Fairhope, AL

Access cutting-edge high risk cardiovascular disease treatment through this clinical trial at a research site in Fairhope. Study-provided care at no cost to qualified participants.

Sponsored by Alnylam Pharmaceuticals

Quick Self-Assessment

See if you qualify for this Fairhope location

Preparing your pre-screening questions…

Expert Care in Fairhope

Access high risk cardiovascular disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related high risk cardiovascular disease treatment provided free

Apply for This Fairhope Location

Check if you qualify for this high risk cardiovascular disease clinical trial in Fairhope, AL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Fairhope

    Convenient for AL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Fairhope site if eligible
  4. 4Begin participation

About This High Risk Cardiovascular Disease Study in Fairhope

The purpose of this study is to evaluate whether zilebesiran versus placebo reduces the risk of cardiovascular (CV) death, nonfatal myocardial infarction (MI), nonfatal stroke, or heart failure (HF) events. This is an event-driven study that will continue until the targeted number of positively adjudicated primary endpoint clinical outcome events (COEs) have been reached.

Sponsor: Alnylam Pharmaceuticals

Who Can Participate

Inclusion Criteria

Is 18 years or older for patients with established cardiovascular disease (CVD)
Is 55 years or older for patients with high risk for CVD
Has established CVD (defined as coronary, cerebrovascular, or peripheral artery disease) or high risk for CVD
Has treated hypertension on stable therapy with at least 2 standard of care antihypertensive medications, one of which must be a thiazide, thiazide-like, or loop diuretic

Exclusion Criteria

Has known history of secondary hypertension
Has symptomatic orthostatic hypotension
Has alanine aminotransferase (ALT) or aspartate aminotransferase (AST) \>3×upper limit of normal (ULN)
Has total serum bilirubin \>1.5×ULN
Has international normalized ratio (INR) \>1.5
Has serum potassium \>4.8 mEq/L
Has estimated glomerular filtration rate (eGFR) \<30 mL/min/1.73m\^2

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Fairhope?

Yes, this clinical trial (NCT07181109) has an active research site in Fairhope, AL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

High Risk Cardiovascular Disease Treatment Options in Fairhope, AL

If you're searching for high risk cardiovascular disease treatment options in Fairhope, AL, this clinical trial (NCT07181109) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Fairhope research site is actively enrolling participants for this clinical trial. You'll receive care from experienced high risk cardiovascular disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all high risk cardiovascular disease clinical trials near you to find additional studies recruiting in your area.

More Heart Disease Trials in Fairhope, AL

See all heart disease clinical trials recruiting in Fairhope — not just this study.

Browse Heart Disease Trials in Fairhope

Ready to Join in Fairhope?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Fairhope, AL